Procept Biorobotics
PRCT
250 hedge funds and large institutions have $3.65B invested in Procept Biorobotics in 2024 Q3 according to their latest regulatory filings, with 72 funds opening new positions, 87 increasing their positions, 70 reducing their positions, and 23 closing their positions.
213% more first-time investments, than exits
New positions opened: 72 | Existing positions closed: 23
36% more capital invested
Capital invested by funds: $2.69B → $3.65B (+$968M)
24% more repeat investments, than reductions
Existing positions increased: 87 | Existing positions reduced: 70
24% more funds holding
Funds holding: 202 → 250 (+48)
2.52% more ownership
Funds ownership: 85.5% → 88.02% (+2.5%)
0% more funds holding in top 10
Funds holding in top 10: 8 → 8 (0)
9% less call options, than puts
Call options by funds: $23.3M | Put options by funds: $25.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$64.3M |
| 2 |
Axa
Paris,
France
|
+$41.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$24.7M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$22.9M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$16.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$50.8M |
| 2 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$50.8M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$27.8M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$19.5M |
| 5 |
PE
Point72 Europe
London,
United Kingdom
|
-$15.8M |
PRCT Hedge Fund Activity: Q3 2024 in Review
250 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Procept Biorobotics (PRCT) for Q3 2024, worth a combined $3.65B — up 36% from $2.69B a quarter earlier.
Buyers outnumbered sellers: 72 funds opened new PRCT positions and 23 closed out — a net gain of 49 holders — while 87 added to existing stakes and 70 trimmed.
The largest buyer was Westfield Capital Management, opening a new position worth an estimated $64.3M. The largest seller was T. Rowe Price Investment Management, cutting an estimated $50.8M.
- 250 institutional investors held Procept Biorobotics (PRCT) as of Q3 2024, up from 202 in Q2 2024.
- Funds reported $3.65B of Procept Biorobotics stock for Q3 2024, up 36% quarter-over-quarter.
- 72 funds opened new Procept Biorobotics positions in Q3 2024 and 23 closed out, a net change of +49 holders.
- The largest Procept Biorobotics buyer in Q3 2024 was Westfield Capital Management, an estimated $64.3M added.
- The largest Procept Biorobotics seller in Q3 2024 was T. Rowe Price Investment Management, an estimated $50.8M sold.
Based on aggregated 13F filings for Q3 2024.